Company profilePharmaceutical#153 of 1,318 in Pakistan✓ No DRAP alerts

PDH LABORATORIES (PVT) LTD

Pharmaceutical company · 113 brands · 135 molecules

Ranked #43 of 207 companies in Quinolone Antibacterials

113 registered products 37 pharmaceutical brands 135 distinct molecules 0 DRAP alerts

Company overview

113
registered products
37
pharmaceutical brands
135
distinct molecules
12
therapeutic classes
0
DRAP alerts

PDH LABORATORIES (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 113 product registrations across 135 distinct molecules. It is the 153rd largest registrant in Pakistan by product count, and ranks 43rd of 207 in Quinolone Antibacterials. Its portfolio is concentrated in Quinolone Antibacterials and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by PDH

39 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Antiemetics & Antinauseants 1
Antimycotics Systemic Use 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

37
ceilings with an approval date
4
not revised in 2+ years
2024
oldest approval year
20244
202533
Longest without revision

Top molecules by brand count

Therapeutic classes

Quinolone Antibacterials · 4Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 3Other Beta-Lactam, Cephalosporins & Penems · 3Antiinflammatory And Antirheumatic Products · 2Anti-Infective, Ophthalmologicals · 2Opioids · 1Vitamin A, D & Combinations · 1Cough Expectorant · 1Eye Conditions · 1Antispasmodic & Anticholinergic · 1Antiepileptics · 1Antianemic, Iron Preparations · 1

Conditions treated

Glaucoma/Mydriasis · 1Hypertension · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official106 products · Rs 1.8 – Rs 3,700.22
Servaid2 products · Rs 330 – Rs 780
Median across source: Rs 555

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NEUTRO PHARMA (PVT) LTD. holds 117 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole
BIO LABS (PVT) LTD. holds 125 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtesunateAscorbic Acid
MEDIATE PHARMACEUTICALS (PVT) LTD holds 101 molecules not in this portfolio
AcyclovirAlendronateAmlodipineAmpicillinAmpicillin BaseAnastrozole

Get the full profile for PDH

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.